Results 191 to 200 of about 36,636,285 (336)

Developing Patient-Reported Outcome Measures of Timely Experience of Diagnosis (PROMOTE-Dx) for Cancer: Survey and Quality Measure Development Report.

Rand Health Q
Price RA, Berdahl CT, Bradley MA, Marsolais E, Pevnick JM, Schlang D, Tolpadi AA, Ye F, O'Hanlon CE.   +8 more
europepmc   +1 more source

Anisotropic shape-shifting robotic matter enabling versatile collective behaviors. [PDF]

Nat Commun
Zhang Y, Huang C, Li S.
europepmc   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

Molecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur, Joel Rodrigues Vitória, Manuel Saiselet, Ligia Craciun, Denis Larsimont, Anne Lefort, Frédérick Libert, Carine Maenhaut, Sabine Costagliola, Maxime Tarabichi, Mirian Romitti, Vincent Detours   +11 more
wiley   +1 more source

Research on the Elastocaloric Effects Performance of the Fe14.6Ni(at%) Alloy via Successive and Pulsing Loading Methods: A Molecular Dynamics Study. [PDF]

Materials (Basel)
Li X, Gong Y, Yang Y, Chen G, Zhou L, Kang J, Wang Y, Lv C.   +7 more
europepmc   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

Annual report, report on Connecticut's continuous improvement plan

Annual; Description based on: Oct. 2003; title from cover (agency web site, viewed Sept.
Connecticut Birth to Three System.
core  

Breaking the phase noise-mode purity trade-off in long-loop OEOs via cascaded zero-dispersion recirculating loops. [PDF]

Light Sci Appl
Wang Z, Bernal S, Plant DV, Chen LR.
europepmc   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Cancer‐associated mutations in endometriosis reframe a benign disease through molecular oncology

Molecular Oncology, EarlyView.
This review aims to comprehensively analyse cancer‐associated somatic mutations (CAMs) present in endometriotic lesions, emphasizing their biological roles, spatial distribution and implications for translational applications in medicine. By contextualizing a benign state within a genomic framework, this analysis seeks to establish its value as a ...
Clarissa Mujacic, Maria Concetta Vitale, Rita Siino, Emilia Di Giovanni, Carla Ferrante Bannera, Enrico Di Marco, Andrea Gottardo, Tancredi Didier Bazan Russo, Nadia Barraco, Alessandro Perez, Valerio Gristina, Antonio Galvano, Giuseppe Badalamenti, Antonio Russo, Viviana Bazan, Lorena Incorvaia   +15 more
wiley   +1 more source

Insight into functionality and bioactive properties of whey protein/beta-glucan complex discrepancy during different pH-induced phase transition. [PDF]

Food Chem X
Xu H, Mu Z, Wang H, Wen X, Hu J, Jiang Z, Gantumur MA.   +6 more
europepmc   +1 more source